Kayne Anderson Rudnick Investment Management LLC Novartis Ag Transaction History

Kayne Anderson Rudnick Investment Management LLC

  • $39.9 Billion
  • Q2 2024

A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 10,225 shares of NVS stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,225
Previous 10,594 3.48%
Holding current value
$1.13 Million
Previous $1.02 Million 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $34,158 - $39,619
-369 Reduced 3.48%
10,225 $1.09 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $63,735 - $72,566
-669 Reduced 5.94%
10,594 $1.02 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $257,894 - $283,804
-2,795 Reduced 19.88%
11,263 $1.14 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $180,081 - $199,852
-1,901 Reduced 11.91%
14,058 $1.43 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $43,391 - $49,202
469 Added 3.03%
15,959 $1.61 Million
Q1 2023

May 16, 2023
SELL
$80.03 - $92.81 $26,329 - $30,534
-329 Reduced 2.08%
15,490 $1.43 Million
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $105,694 - $129,435
1,399 Added 9.7%
15,819 $1.44 Million
Q3 2022

Nov 16, 2022
BUY
$74.61 - $87.26 $1.08 Million - $1.26 Million
14,420 New
14,420 $1.1 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $1.14 Million - $1.34 Million
-15,305 Closed
0 $1.1 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $34,382 - $40,031
427 Added 2.87%
15,305 $1.29 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $16,983 - $19,211
-212 Reduced 1.4%
14,878 $1.31 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $67,665 - $74,822
-849 Reduced 5.33%
15,090 $1.32 Million
Q3 2021

Nov 12, 2021
BUY
$81.78 - $95.14 $35,410 - $41,195
433 Added 2.79%
15,939 $1.3 Million
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $10,143 - $11,203
-119 Reduced 0.76%
15,506 $1.42 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $71,559 - $84,388
-857 Reduced 5.2%
15,625 $1.34 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $36,536 - $44,193
-468 Reduced 2.76%
16,482 $1.56 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $168,140 - $186,277
2,047 Added 13.74%
16,950 $1.47 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $347,999 - $391,730
-4,300 Reduced 22.39%
14,903 $1.3 Million
Q1 2020

May 15, 2020
SELL
$70.67 - $99.01 $216,320 - $303,069
-3,061 Reduced 13.75%
19,203 $1.58 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $8,772 - $9,918
104 Added 0.47%
22,264 $2.11 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $575,513 - $634,181
-6,728 Reduced 23.29%
22,160 $1.93 Million
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $197,171 - $242,672
2,615 Added 9.95%
28,888 $2.64 Million
Q1 2019

Jun 12, 2019
SELL
$75.32 - $86.15 $18,528 - $21,192
-246 Reduced 0.93%
26,273 $2.53 Million
Q1 2019

May 10, 2019
SELL
$75.32 - $86.15 $246,221 - $281,624
-3,269 Reduced 10.97%
26,519 $2.55 Million
Q4 2018

Feb 06, 2019
SELL
$73.66 - $82.02 $160,578 - $178,803
-2,180 Reduced 6.82%
29,788 $2.56 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $24,433 - $28,261
365 Added 1.15%
31,968 $2.75 Million
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $107,685 - $121,704
-1,659 Reduced 4.99%
31,603 $2.39 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $247,209 - $295,534
3,512 Added 11.81%
33,262 $2.69 Million
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $121,876 - $130,823
1,685 Added 6.0%
29,750 $2.5 Million
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $2.08 Million - $2.17 Million
28,065
28,065 $2.41 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kayne Anderson Rudnick Investment Management LLC Portfolio

Follow Kayne Anderson Rudnick Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email